Skip to Content [0]

Skip to Navigation [1]

Heart Attack Medication — Continuing

Look for differences of at least four percent.

Smaller differences often are not significant

Heart Attack Medication — Continuing

How HMOs scored on meeting national standards of care
  • 0% (Worse)
  • (Better) 100%
Kaiser Permanente - Northern California 85% Horizontal bar, 85 units
Kaiser Permanente - Southern California 82% Horizontal bar, 82 units
Blue Shield of California HMO 72% Horizontal bar, 72 units
Blue Cross HMO - CaliforniaCare 71% Horizontal bar, 71 units
PacifiCare of California 69% Horizontal bar, 69 units
Health Net of California, Inc. 68% Horizontal bar, 68 units
Aetna Health of California Inc. 67% Horizontal bar, 67 units
CIGNA HealthCare of CA 59% Horizontal bar, 59 units
Western Health Advantage Not rated

About This Rating

What Was Measured?

What percentage of HMO members who were hospitalized for a heart attack continued to receive beta blocker drugs, for the six months following the heart attack, to ease heart pain and help avoid a repeat attack or stroke?

These results are based on a sample of HMO patient administrative and medical records.

Why Is It Important?

Anyone who has had a heart attack is at a higher risk of having another heart attack or a stroke. Medicines called beta-blockers help prevent a repeat heart attack or stroke. These drugs ease how hard the heart has to work — one mark of good care is seeing that patients continue to use this heart medication for a period of time after the damage of a heart attack.